Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer

Table 2 LVEF in Patients With and Without Cardiotoxicity for Time Points T0, T1, and T2

Time	LVEF, %^a
Time	Patients With Cardiotoxicity (n = 13)	Patients Without Cardiotoxicity (n = 53)
T0	66 (±6)	65 (±4)
T1	60 (±7)	63 (±5)
T2	54 (±6)	63 (±4)

Abbreviations: LVEF left ventricular ejection fraction, T0 baseline (pretreatment), T1 time from start of chemotherapy to first echocardiogram, T2 time from start of chemotherapy to second echocardiogram
^aData are expressed as mean (±SD)

ISSN: 1471-2407